Pet pharma boom draws scrutiny

- Pet wellness spending is moving from flea meds and vaccines into daily supplements, premium diets, and gut-health products — and vets are pushing back. - In the U.S., 53% of dog owners now give vitamins or supplements; regulators still treat most pet “supplements” as food or drugs. - That matters because demand is outrunning evidence — especially for multivitamins, probiotics, and travel-linked vaccine decisions.

Pet medicine used to mean the obvious stuff — vaccines, parasite control, antibiotics, pain drugs. Now it means wellness stacks too. Soft chews for joints, probiotic powders for digestion, calming blends, skin-and-coat oils, breed-specific toppers. The boom is real, but so is the backlash. Vets and regulators are basically asking the same question: which of these products actually help, and which ones are just human wellness habits repackaged for dogs and cats? (americanpetproducts.org) ### Why is pet pharma suddenly bigger than medicine? Because the category has widened. Owners are treating pets more like family members and extending their own preventive-health habits to them. In the U.S., more than half of dog owners and about one-third of cat owners now give vitamins or supplements, (americanpetproducts.org)ptions alone. (americanpetproducts.org) ### What are people buying? Multivitamins are still a big chunk of the market, but the faster-growing story is targeted products — probiotics and prebiotics for digestion, joint formulas, omega blends for skin and coat, and calming chews. Market trackers keep pointing to digestive-health products as one of the fastest-growing slices, which fits the broader shift from treating illness to trying to prevent it. (mordorintelligence.com) ### So why are vets uneasy about multivitamins? Because a lot of pets eating complete commercial diets may not need them. That does not mean supplements are useless. It means the default case is murkier than the marketing suggests. The risk is not just wasted money. Oversupplementation can cause harm, especially when owners (mordorintelligence.com)gged by veterinary toxicologists include iron, manganese, alpha lipoic acid, methionine, and vitamin D3. (avma.org) ### Are vaccines part of this argument too? Yes, but in a different way. The “over-vaccination” debate is usually not about core vaccines being bad. It is about whether every pet needs every noncore shot on a fixed schedule. Current canine guidelines are risk-based — core vaccines for all dogs, then extras based(avma.org)core group for dogs. So the real fight is not vaccines versus no vaccines. It is one-size-fits-all medicine versus individualized preventive care. (aaha.org) ### Where do regulators come in? Here is the catch — U.S. law does not create a neat “dietary supplement” bucket for pets the way it does for humans. FDA says products sold as animal supplements are generally regulated as either food or new animal drugs, depending on what they claim to do. That leaves a fuzzier market than many owners assume, especially when labels imply health benefits without drug-level evidence. (fda.gov) ### Why does travel make this messier? Because travel rules force owners to think about vaccines, tests, and certificates in a very concrete way. USDA says pets traveling abroad may need destination-specific vaccinations, treatments, and endorsed health certificates. CDC, meanwhile, regulates animals entering the U.S. to limit disease spread. So a pet owne(fda.gov) more documentation and, sometimes, more shots. (aphis.usda.gov) ### What is happening in India? India looks like a compressed version of the same shift. Market researchers describe rising demand for premium, functional, and natural pet supplements, with probiotics, omegas, and joint-support products gaining traction as owners spend more on preventive care. The market is still much smaller than the U.S., but the direction is the point — pet wellness is global now. (imarcgroup.com) ### Bottom line? The pet pharma boom is not really about more medicine. It is about medicine, food, and wellness blurring together. That is good news when products are targeted and evidence-based — but not when marketing outruns dosing, proof, and common sense. (fda.gov)

Get your own daily briefing

Scout delivers personalized news, insights, and conversations tailored to your role and industry.

Download on the App Store

Shared from Scout - Be the smartest in the room.